Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Jul 2022 for Marvel Biosciences Corp. Formerly Alphanco Venture Corp., €7,592.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Jeremy David Fehr: trading record in brief
All filings by Jeremy David Fehr on record concern Marvel Biosciences Corp. Formerly Alphanco Venture Corp. Over a trading history stretching from 14 June 2021 to 18 July 2022, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 29 July 2022 came the latest disclosure, a transaction for €7,592 in Marvel Biosciences Corp. Formerly Alphanco Venture Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Jeremy David Fehr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
100,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3982204
Common SharesTSXSEDI:3766676
2 of 2 declarations
